Recurrent Neuroblastoma Recruiting Phase 3 Trials for Melphalan (DB01042)

Also known as: Neuroblastoma Recurrent

IndicationStatusPhase
DBCOND0028756 (Recurrent Neuroblastoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs